This clinical trial aimed at comparing the intensity of pain and bruising by subcutaneous and intramuscular injections using and retractable fixed syringes and needles and syringes with no needles combined, at a public hospital in Sao Paulo, for six months. We evaluated the perception of pain in case of intramuscular (n=1000) and subcutaneous injections (n=240).
Introduction
The World Health Organization (WHO) recommends the use of safety devices for intramuscular, subcutaneous and intradermal medication administration. These devices avoid equipment reuse and health professionals' contact with piercing and cutting material like needles, which increase the risk of biological accidents (1) .
Between two and three million percutaneous accidents involving needles contaminated with biological material occur every year (2) (3) . A North American study showed that health professionals are exposed to between 385,000 and 800,000 piercing and cutting accidents per year, involving risks of transmitting blood-borne pathogens like hepatitis B, C and HIV, among others (4) .
The impact of these accidents includes emotional damage, decreased productivity at work and financial impacts for the health system (5) . Between 1995 and 2003, the National Surveillance System for Health Care Workers (NaSH) demonstrated that 26% of piercing and cutting accidents are associated with needle manipulation in patients (2,662/10,239) and 5% with needle recapping 1065 www.eerp.usp.br/rlae Lamblet LCR, Meira ES, Torres S, Ferreira BC, Martucchi SD.
(512/10,239). Six devices are responsible for 80% of injuries, 56% involving hollow needles and 30% hypodermal needles (5,612/18,708) . Sixty-four percent of piercing and cutting accidents could be avoided.
The Centers for Disease Control and Prevention (CDC) recommends that institutions establish a program to enhance a safety culture that includes the assessment of new safety devices for health professionals (6) .
A systematic review on the occurrence of occupational infection by HIV in health workers in Brazil showed that the four identified cases involved nursing professionals and that contamination was due to percutaneous exposure (7) .
A study on accidents involving piercing and cutting material among nursing workers, between 1985 and 2000, which analyzed 39 international and 16 Brazilian studies, appointed that the main factors associated with piercing and cutting accidents were needle handling and recapping (8) .
A study conducted at a tertiary hospital between controls, which assessed the factors associated with percutaneous accidents in the nursing team, showed that one of the predictors was needle recapping (OR 9.48; CI 95%) (9) .
In São Paulo State, Brazil, the Biological Accident Notification System (SINABIO) was created as from
Out of 14,096 accidents notified until 2006
in approximately 20% of cities in the State, it was evidenced that 85.5% were percutaneous, 57.7% involved nursing professionals and 4.2% were due to needle recapping (10) . In Brazil, in 2005, Ministry of Health Decree 485 was approved, which sets standards for occupational safety and health in health establishments -NR-32 (11) . This Decree established a deadline to implant safety devices for all piercing and cutting material (12) . Implanting safety devices demands tests to assess their efficacy and adequacy to their goals. Engineering of these devices should permit easy handling, passive activation and minimal changes in the usage technique (1) (2) 4, 6) .
In
Brazil, intramuscular, intradermal and subcutaneous drug administration is performed, involving the exchange of the needle through which the substance is aspirated to apply the drug. These recommendations are mentioned in different technical books and are based on established practices, but are not accompanied by scientific evidence (13) (14) (15) . Most drug administration manuals do not address the need to change needles in order to apply injections (16) (17) .
In a literature review carried out LILACS and
Medline, Pubmed and a dissertation and thesis bank, using the descriptors: "pain", "hematoma" "exchange", "intradermal injections", "subcutaneous injections", "intramuscular injections" combined with "methods", "adverse events", "prevention" and "control", studies on the theme were identified.
One study recommends changing needles after aspiring the drug to guarantee cleanliness, needle cutting, adequate caliber and length, thus avoiding pain and contact between the drug and subcutaneous tissue (18) .
Other studies also recommend changing needles for injection application as good practice. These recommendations propose that, in certain situations, one should clean the needles with sterile gauze or transfer the drug to another sterile syringe before its administration (19) (20) . Nevertheless, risks of contaminating the drug and equipment and accidents involving piercing and cutting material should be taken into account.
The Brazilian Diabetes Society recommends insulin preparation and application using needles combined with syringes. When administering two types of insulin, the use of needles not combined with syringes is recommended, so as to guarantee the aspiration of the correct dose (21) . The CDC does not recommend changing needles when applying vaccines (22) .
Three studies cited below assessed pain or bruising, comparing the drug administration technique with or without needle changing.
The study that compared insulin administration with and without needle changing demonstrated that the diameter of the bruise did not decrease when changing needles (p=0.87) (23) .
The trial that involved patients (n=70) who received intramuscular viscous drugs through two techniques, with and without needle changing, demonstrated results without differences in pain intensity levels measured on the numerical scale in both groups (p<0.05) (24) .
The randomized trial that compared two groups of pediatric patients between six months and six years of age who were receiving the same volume of a double vaccination (tetanus-diphtheria) from the same laboratory through the intramuscular route was conducted during eight weeks. The same technique was used for the application, with or without needle change.
In that study, 423 patients participated and 346 forms were returned (81.8%). No statistically significant differences were found in bruising levels, hardening of the site or edema in the two compared groups. Likewise, no statistically significant difference was observed in systemic effects either, including fever, vomiting, appetite loss and crying (25) . 
Aims
To compare pain intensity using the numerical scale (0 to 10), in case of intramuscular injection and subcutaneous injection, applying retractable fixed needle syringes and the technique with needle switching;
To compare bruising after subcutaneous insulin administration, using retractable fixed needle syringes and the technique with needle switching.
Method
This The population comprised patients who were sequentially included in the study through a draft system, in which random figures in sealed and dark envelopes were used. (26) . On the assessment form, all study variables of interest (initials, gender, age, baseline disease, hospitalization date, medication use, body mass index, bruise size, application site, drug name and administered volume) were registered. For those patients who received the subcutaneous injections, the bruise size in millimeters was included, when present.
Sample design and size
The body mass index was verified through the following formula: weight in kilos /(height in meters) (2) .
After the patient's consent, the assessment form was completed, taken from a sealed envelope, which the professional opened, after which (s)he applied the intramuscular or subcutaneous injection, using the conventional technique or retractable fixed syringe, according to the randomization. After the injection application, the patient was shown a numerical scale ranging from 0 to 10 in order to score the pain the injection application had caused. In the subcutaneous injection group, after 24 hours, the nurse measured bruise size with a millimeter ruler. Patients were included in the study until completing the necessary sample size.
Syringes and needles used
Conventional technique: for the intramuscular injection, a 5-milliliter syringe was used. After aspiring the drug with an 18G x 1.5" (40 x 1.2 mm) needle, it was disconnected from the syringe, after which a 22G x 1¼"
(30 x 0.7 mm) needle was connected for the application.
For the subcutaneous injection, a 1-milliliter syringe was used with 100 UI, connected with a fixed 26G x 0.5" (13 x 0.45 mm) needle.
Lamblet LCR, Meira ES, Torres S, Ferreira BC, Martucchi SD. 
Injection application technique
Subcutaneous injection: the administered drug was insulin, according to the units prescribed to the patient. The application site was determined using an instrument to assess the body area turnover used for insulin application to patients, included in their files.
After determining the application site and performing skin antisepsis, the cutaneous fold was fixed with the non-dominant hand and the needle was introduced at a 90º angle. Without aspiration, the insulin was injected. In the conventional technique, the needle was rapidly withdrawn and the application site was slightly compressed with a swab without massaging. In the retractable needle technique, the same procedure was performed but, at the end of the application and full compression of the vial, the retractable device introduced the needle inside the body of the syringe before its removal from the subcutaneous tissue.
Intramuscular injection: the injected drugs were
prescribed for the patient's treatment. The volume ranged from 1 to 4 ml. Intramuscular injections applied in the dorsal-gluteal region were assessed, as that was the body region professionals who administered medication at the Emergency Care commonly used at the institution for this type of procedure.
The gluteal region was divided in four parts and the injection was applied in the external upper quadrant.
After skin antisepsis, the needle was introduced at a 90º angle. After applying the injection and removing the needle, the application site was slightly massaged. In the retractable needle technique, the same technique was performed but, at the end of the application and full compression of the vial, the retractable device introduced the needle inside the body of the syringe before it was removed from the dorsal-gluteal region.
At the medical-surgical hospitalization Unit, patients who received subcutaneous insulin were assessed.
Control group patients received insulin through the conventional technique. The insulin application site was defined according to each patient's application turnover and was outlined with a specific pen for skin marking after the application. Patients were assessed 24 hours later to detect the presence of bruising at the application site.
At the Emergency Care Unit, patients who received intramuscular drugs were assessed. All drugs were applied in the patients' dorsal-gluteal region at a private room. The dorsal-gluteal region used for applying the intramuscular injections, as that was the body area standardized for this type of procedure at the institution's Emergency Care Unit.
The collected data were processed and launched in an electronic Excel ® worksheet. Student's t-test was used to analyze the variables, with significance set at 5%. Thus, it was considered that differences existed between groups if p <0.05. Table 1 shows the active ingredients and the volume of drugs used in intramuscular injections, applied with the conventional technique and retractable fixed needles. The administered drugs were prescribed for patient treatment at the Emergency Care Unit. Drug volume ranged between 1 and 4 ml, according to the drug or diluent used.
Results
The comparison of volume distribution per technique, separately for each pain degree, showed that, for the total group of patients, no difference occurred in the mean pain score according to the different volumes used (p=0.364), according to Table 2 . For this comparison, the Chi-Square test was used, with significance set at 5%.
The results show no difference in volume distribution between the technique for any pain level. Lamblet LCR, Meira ES, Torres S, Ferreira BC, Martucchi SD. On the average, the bruising score is higher in the patient group in which the conventional technique was used (p<0.029), according to Table 5 . In clinical practice, the belief exists that drawing back retractable needles before removing them from the skin in case of subcutaneous injections could provoke traumas and bruising. This study, on the other hand, evidenced no major bruising when using retractable fixed needles to apply subcutaneous injections. This finding confirms that using the safety device to apply subcutaneous injections is safe to use with patients.
Initially, the researchers had planned to assess the intramuscular injection application using one single drug and volume but, after a pilot study at the Emergency Care Unit, it was observed that the time needed for data collection could turn the study unfeasible. Therefore, the decision was made to administer volumes between 1 and 
